今天,我们来看看这本SCI期刊:Cellular & Molecular Immunology。从现有的记录来看,Cellular & Molecular Immunology 的2022年影响因子(JCR2021)是22.096分,2021年是11.53分,2020年是8.484分。
关于此刊的具体情况,大家可以看看:
Cellular & Molecular Immunology 的收稿范围,期刊是如此介绍的(截取部分内容),详情请阅读:
https://www.nature.com/cmi/aims
Cellular & Molecular Immunologyis a monthly journal from the Chinese Society of Immunology and the University of Science and Technology of China. Covering both basic immunology research and clinical applications,Cellular & Molecular Immunologyprovides the latest information and advancements in our understanding of the immunological response of the host, bothin vitroandin vivo.
The journal publishes Articles, Review Articles, Mini Reviews and Short Communications and Correspondences in all areas of cellular and molecular immunology, including but not limited to:
clinical immunology
comparative immunology
immunobiology
immunogenetics
immunological techniques
immunopathology
immunopharmacology
infection immunology
neuroimmunology
transplantation immunology
tumor immunology
veterinary immunology
-
Received: 24 March 2022, Accepted: 2 April 2022
-
Received: 12 September 2021, Accepted: 8 December 2021
-
Received: 30 August 2021, Accepted: 15 November 2021
-
Received: 1 October 2021, Accepted: 20 March 2022
影响因子
Cellular & Molecular Immunology 的2022年影响因子(JCR2021)是22.096分,2021年是11.53分,2020年是8.484分。
此图为“51选刊”绘制
如果还没有注册过账户,只需点击“Register for an account”注册账户即可!
有22+分以上发表要求的,来看看这个潜力股的SCI期刊吧!
版权声明:本文转自“51选刊”,文章转载只为学术传播,不代表本号观点,无商业用途,版权归原作者所有,如涉及侵权问题,请联系我们,我们将及时修改或删除。
添加微信获取最新优惠、出版政策、课程直播信息,随时咨询客服/编辑,了解更多实时资讯